步长制药: 山东步长制药股份有限公司关于完成工商变更登记的公告

Core Viewpoint - The company has completed the registration of changes in its business license following the reduction of registered capital through the cancellation of repurchased shares [1][2][3] Group 1: Share Repurchase and Capital Reduction - The company held board meetings on April 25, 2025, and May 26, 2025, to approve the change of purpose for repurchased shares totaling 44,853,573 shares and 6,620,630 shares, respectively, to "reduce registered capital" [1][2] - The company completed the cancellation of repurchased shares on August 12, 2025, as per the announcements made on the Shanghai Stock Exchange [2] Group 2: Business Registration Changes - The company has successfully completed the business registration change and received a new business license from the Heze Market Supervision Administration [3] - The updated registered capital is RMB 1,054,484,432 [3] - The company operates in the production of various pharmaceutical forms, including tablets, hard capsules, granules, and oral liquids [3]